1. Home
  2. EVO vs BAK Comparison

EVO vs BAK Comparison

Compare EVO & BAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.65

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Braskem SA ADR

BAK

Braskem SA ADR

HOLD

Current Price

$2.91

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
BAK
Founded
1993
1972
Country
Germany
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
EVO
BAK
Price
$3.65
$2.91
Analyst Decision
Strong Buy
Hold
Analyst Count
1
2
Target Price
$7.00
$4.40
AVG Volume (30 Days)
251.6K
898.7K
Earning Date
11-05-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$887,396,457.00
$13,841,708,237.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8.52
$7.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.84
$2.32
52 Week High
$4.80
$5.10

Technical Indicators

Market Signals
Indicator
EVO
BAK
Relative Strength Index (RSI) 71.06 50.48
Support Level $3.10 $2.82
Resistance Level $3.23 $3.09
Average True Range (ATR) 0.08 0.11
MACD 0.08 -0.00
Stochastic Oscillator 96.87 47.77

Price Performance

Historical Comparison
EVO
BAK

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About BAK Braskem SA ADR

Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.

Share on Social Networks: